Showing results (81-90 of 131) with videos related to
Sort By:
Pageof 14
Journal of Immunological Methods|March 22, 2005
Biophotonic cytotoxicity assay for high-throughput screening of cytolytic killingChristine E Brown, Christine L Wright, Araceli Naranjo, et al.Oncotarget|June 21, 2016
Immunotherapy of acute leukemia by chimeric antigen receptor-modified lymphocytes using an improved Sleeping Beauty transposon platformChiara F Magnani, Nice Turazzi, Fabrizio Benedicenti, et al.Scientific Reports|June 4, 2016
T cells expressing CD19-specific Engager Molecules for the Immunotherapy of CD19-positive MalignanciesMireya Paulina Velasquez, David Torres, Kota Iwahori, et al.Cancer Research|May 12, 2011
Reprogramming CD19-specific T cells with IL-21 signaling can improve adoptive immunotherapy of B-lineage malignanciesHarjeet Singh, Matthew J Figliola, Margaret J Dawson, et al.Cancer Research|April 17, 2008
Redirecting specificity of T-cell populations for CD19 using the Sleeping Beauty systemHarjeet Singh, Pallavi R Manuri, Simon Olivares, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|May 11, 2016
Redirecting T-Cell Specificity to EGFR Using mRNA to Self-limit Expression of Chimeric Antigen ReceptorHillary G Caruso, Hiroki Torikai, Ling Zhang, et al.Blood|December 15, 2005
Differentiation of naive cord-blood T cells into CD19-specific cytolytic effectors for posttransplantation adoptive immunotherapyLisa Marie Serrano, Timothy Pfeiffer, Simon Olivares, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|October 12, 2014
Activation and propagation of tumor-infiltrating lymphocytes on clinical-grade designer artificial antigen-presenting cells for adoptive immunotherapy of melanomaMarie-Andrée Forget, Shruti Malu, Hui Liu, et al.Plos One|June 7, 2013
Manufacture of clinical-grade CD19-specific T cells stably expressing chimeric antigen receptor using Sleeping Beauty system and artificial antigen presenting cellsHarjeet Singh, Matthew J Figliola, Margaret J Dawson, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 2, 2015
Genetic Engineering of T Cells to Target HERV-K, an Ancient Retrovirus on MelanomaJanani Krishnamurthy, Brian A Rabinovich, Tiejuan Mi, et al.Pageof 14